After pretreatment with α7nAChR inhibitor, α-BTX, we found that GSS lost the protection against brain infarction and neurological dysfunction and the inhibitive effects on microglial M1 depolarization and NF-κB signaling in both in vivo and in vitro experiments. This evidence concerns the gene NFKB1 and brain infarction.